Seraphim Space Investment Trust (LSE: SSIT) leans on ICEYE re-rating and SpaceX IPO tailwind to consolidate FTSE 250 entry
Read More Pharma Industry News BioHarvest Sciences completes nearly $20m financing round — what it means for shareholders and future growth Find out how BioHarvest Sciences’ $19.9 million public offering is shaping its expansion plans, investor sentiment, and biotech growth outlook today. bySoujanya RaviNovember 11, 2025